TMBR Insider Trading - Timber Pharmaceuticals Inc

Ações de Insider

47,889,840 shares

Pontuação de Sentimento de Insider

A Pontuação de Sentimento de Insider encontra as empresas que estão sendo compradas por insiders corporativos.

É o resultado de um modelo quantitativo sofisticado e multifatorial que identifica empresas com os mais altos níveis de acumulação por insiders. O modelo de pontuação usa uma combinação do número líquido de insiders comprando nos últimos 90 dias, o total de ações compradas como um percentual do float, e o total de ações possuídas por insiders. A escala varia de 0 a 100, com números mais altos indicando um maior nível de acumulação em relação aos seus pares, e 50 sendo a média.

Frequência de Atualização: Diariamente

Veja as Principais Escolhas dos Insiders, que fornece uma lista de empresas com a maior acumulação de insiders.

Veja as Ações de Maior Classificação

Pontuação de Sentimento dos Oficiais

A Pontuação de Sentimento de Officer encontra empresas que estão sendo compradas por Oficiais Corporativos.

Por definição, Oficiais Corporativos são Insiders Corporativos, mas, ao contrário de alguns outros Insiders (Acionistas de 10% e Membros do Conselho), os Oficiais trabalham para a empresa diariamente, e eles usam seu próprio dinheiro ao negociar. (Acionistas de 10% e Membros do Conselho muitas vezes são gestores de fundos que gerenciam o dinheiro de outras pessoas.) Como tal, as negociações de insiders feitas por Oficiais são muito mais significativas e devem ser tratadas apropriadamente.

Como a Pontuação de Sentimento dos Insiders, a Pontuação de Sentimento de Officer é o resultado de um modelo quantitativo sofisticado e multifatorial que identifica empresas com os mais altos níveis de acumulação por parte dos oficiais.

Frequência de Atualização: Diariamente

Veja as Principais Escolhas dos Insiders, que fornece uma lista de empresas com maior sentimento dos insiders.

Veja as Ações de Maior Classificação

Principais Métricas de Insider

Este cartão mostra como a empresa se classifica em várias métricas internas. O percentil mostra como esta empresa se compara a outras empresas nos mercados dos EUA. Classificações mais altas são indicativas de situações melhores.

Por exemplo, geralmente aceita-se que a compra interna é um indicador positivo, portanto, empresas com mais compras internas teriam classificações mais altas do que empresas com menos compras internas (ou até mesmo venda interna).

Número Líquido de Insiders Comprando (Classificação)

N/A

Número Líquido de Insiders Comprando é o número total de insiders comprando menos o número total de insiders vendendo nos últimos 90 dias. O percentil é mostrado aqui (varia de 0 a 100%).

Percentual do Float Comprado por Insiders (Classificação)

N/A

Percentual do Float Comprado por Insiders é o número total de ações compradas por insiders menos o número total de ações vendidas por insiders nos últimos 90 dias, dividido pelo total flutuante e multiplicado por 100.

Gráfico de Negociação de Insider

Timber Pharmaceuticals Inc negociações de insiders são mostradas no seguinte gráfico. Insiders são oficiais, diretores ou investidores significativos em uma empresa. Em geral, é geralmente ilegal para insiders realizarem negociações em suas empresas com base em informações materiais, não públicas. Isso não significa que seja ilegal para eles fazerem quaisquer negociações em suas próprias empresas. No entanto, eles devem relatar todas as negociações à SEC através de um Formulário 4.

Roster de Insider e Métricas de Lucratividade

Esta tabela mostra a lista de insiders conhecidos, e é gerada automaticamente a partir de arquivamentos divulgados à SEC. Além dos nomes, título mais recente, e designação de diretor, oficial ou proprietário de 10%, fornecemos as últimas participações divulgadas. Adicionalmente, quando possível fornecemos o desempenho comercial histórico do insider. O desempenho comercial histórico é uma média ponderada do desempenho de transações reais de compra no mercado aberto feitas pelo insider. Para mais informações sobre como isso é calculado, assista este webinar no YouTube.

See our leaderboard of most profitable insider traders.

Insider	Lucro Médio (%)	Ações Possuídas	Ajuste de Divisão

Report errors via our new Insider Auditing Tool

Acompanhar Históricos de Compras de Insiders - Análise de Lucro a Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra de insider não planejada, feita no mercado aberto em TMBR / Timber Pharmaceuticals Inc. Esta análise ajuda a entender se o insider gera consistentemente retornos anormais, e vale a pena ser seguido. Esta análise é para um ano após cada negociação, e os resultados são teóricos .

A tabela a seguir mostra as compras mais recentes no mercado aberto que não fizeram parte de um plano de negociação automática.

Data de Negociação	Insider	Reported Shares	Preço Reportado	Ações Ajustadas	Preço Ajustado	Base de Custo	Dias até Máx	Preço em Máx	Lucro Máximo ($)	Retorno Máximo (%)
2021-12-15	Koconis John	20,000	0.3843	400	19.2150	7,686	334	1.8900	-6,930	-90.16
2021-11-23	Sitar Edward J	15,000	0.4600	300	23.0000	6,900
2021-11-23	Mendelsohn Alan	10,000	0.4700	200	23.5000	4,700
2021-03-03	Mendelsohn Alan	1,988	2.1700	40	108.5000	4,314
2018-09-19	Tierney David S	100,000	0.2025	100,000	0.2025	20,250
2017-11-24	Morlock Stephen	330,000	0.1500	330,000	0.1500	49,500
2017-08-01	FRANKLIN RESOURCES INC	250,000	0.3372	250,000	0.3372	84,300

Preço Ajustado é o preço ajustado pelo desdobramento. Ações Ajustadas são as ações ajustadas pelo desdobramento.

TMBR / Timber Pharmaceuticals Inc Insider Trades

Acompanhar Históricos de Vendas de Insiders - Análise de Perda a Curto Prazo

Nesta seção, analisamos a evitação de perda de curto prazo de cada venda de insider não planejada, feita no mercado aberto em TMBR / Timber Pharmaceuticals Inc. Um padrão consistente de evitação de perdas pode sugerir que transações de venda futuras possam prever quedas no preço. Esta análise é para um ano após cada negociação, e os resultados são teóricos .

A tabela a seguir mostra as vendas mais recentes no mercado aberto que não fizeram parte de um plano de negociação automática.

Data de Negociação	Insider	Reported Shares	Preço Reportado	Ações Ajustadas	Preço Ajustado	Base de Custo	Dias até Mín	Preço em Mín	Máxima Perda Evitada ($)	Máxima Perda Evitada (%)
2021-09-02	TardiMed Sciences LLC	225,000	0.9376	4,500	46.8800	210,960	336	0.0960	-210,528	-99.80
2021-09-01	TardiMed Sciences LLC	150,500	0.9227	3,010	46.1350	138,866
2021-08-31	TardiMed Sciences LLC	150,000	0.9116	3,000	45.5800	136,740
2021-08-30	TardiMed Sciences LLC	100,000	0.9266	2,000	46.3300	92,660
2021-08-26	TardiMed Sciences LLC	100,000	0.9184	2,000	45.9200	91,840
2021-08-25	TardiMed Sciences LLC	100,000	0.9126	2,000	45.6300	91,260
2021-08-24	TardiMed Sciences LLC	100,000	0.9253	2,000	46.2650	92,530
2021-08-20	TardiMed Sciences LLC	50,000	0.9079	1,000	45.3950	45,395
2021-08-19	TardiMed Sciences LLC	50,000	0.9540	1,000	47.7000	47,700

Preço Ajustado é o preço ajustado pelo desdobramento. Ações Ajustadas são as ações ajustadas pelo desdobramento.

Histórico de Transações

Clique no ícone de link para ver o histórico completo de transações. As transações relatadas como parte de um plano de negociação automática 10b5-1 terão um X na coluna marcada como 10b-5.

Arquivo Data	Data da Operação	Formulário	Insider	Ticker	Título de Segurança	Código	Direto	Preço de Exercício Preço Unitário	Preço por Unidade	Unidades Alteradas	Valor Alterado (1K)	Opções Restantes	Ações Restantes
2023-08-22	2023-08-20	4	Koconis John	TMBR	Common Stock, par value $0.001 per share	A - Award	D			70,385			70,785
2023-08-22	2023-08-20	4	Mendelsohn Alan	TMBR	Common Stock, par value $0.001 per share	A - Award	D			35,193			35,393
2023-08-22	2023-08-20	4	Lucchese Joseph	TMBR	Common Stock, par value $0.001	A - Award	D			35,193			35,193
2023-04-18	2023-04-15	4	Gaal Lubor	TMBR	Common Stock, par value $0.001 per share	A - Award	D			4,100			6,100
2023-04-18	2023-04-15	4	Pirozzi Gianluca	TMBR	Common Stock, par value $0.001 per share	A - Award	D			4,100			6,100
2023-04-18	2023-04-15	4	Sitar Edward J	TMBR	Common Stock, par value $0.001 per share	A - Award	D			5,327			11,127
2023-04-18	2023-04-15	4	Cohen David E	TMBR	Common Stock, par value $0.001 per share	A - Award	D			4,100			6,100
2022-12-16	2022-12-15	4	Sitar Edward J	TMBR	Common Stock, par value $0.001 per share	A - Award	D		1.6290	2,500	4		5,800
2022-04-19	2022-04-15	4	Lucchese Joseph	TMBR	Stock Option (right to buy)	A - Award	D	0.31		300,000		300,000
2022-04-19	2022-04-15	4	Mendelsohn Alan	TMBR	Stock Option (right to buy)	A - Award	D	0.31		300,000		300,000
2022-04-19	2022-04-15	4	Koconis John	TMBR	Stock Option (right to buy)	A - Award	D	0.31		600,000		600,000
2022-04-19	2022-04-15	4	Cohen David E	TMBR	Stock Option (right to buy)	A - Award	D	0.31		100,000		100,000
2022-04-19	2022-04-15	4	Cohen David E	TMBR	Common Stock, par value $0.001 per share	A - Award	D			100,000			100,000
2022-04-19	2022-04-15	4	Sitar Edward J	TMBR	Stock Option (right to buy)	A - Award	D	0.31		150,000		150,000
2022-04-19	2022-04-15	4	Sitar Edward J	TMBR	Common Stock, par value $0.001 per share	A - Award	D			150,000			165,000
2022-04-19	2022-04-15	4	Pirozzi Gianluca	TMBR	Stock Option (right to buy)	A - Award	D	0.31		100,000		100,000
2022-04-19	2022-04-15	4	Pirozzi Gianluca	TMBR	Common Stock, par value $0.001 per share	A - Award	D			100,000			100,000
2022-04-19	2022-04-15	4	Gaal Lubor	TMBR	Stock Option (right to buy)	A - Award	D	0.31		100,000		100,000
2022-04-19	2022-04-15	4	Gaal Lubor	TMBR	Common Stock, par value $0.001 per share	A - Award	D			100,000			100,000
2022-04-15	2022-03-04	4	Rome Zachary	TMBR	Value Appreciation Rights	M - Exercise	D	0.01		79,326		0
2022-04-15	2022-03-04	4	Rome Zachary	TMBR	Value Appreciation Rights	D - Sale to Issuer	D	0.01		-52,884		79,326
2022-04-15	2022-03-04	4	Rome Zachary	TMBR	Common Stock, par value $0.001 per share	F - Taxes	D		0.2800	-19,630	-5		59,696
2022-04-15	2022-03-04	4	Rome Zachary	TMBR	Common Stock, par value $0.001 per share	M - Exercise	D		0.0100	79,326	1		79,326
2021-12-16	2021-12-15	4	Koconis John	TMBR	Common Stock, par value $0.001 per share	P - Purchase	D		0.3843	20,000	8		20,000
2021-11-24	2021-11-23	4	Mendelsohn Alan	TMBR	Common Stock, par value $0.001 per share	P - Purchase	D		0.4700	10,000	5		10,000
2021-11-24	2021-11-23	4	Sitar Edward J	TMBR	Common Stock, par value $0.001 per share	P - Purchase	D		0.4600	15,000	7		15,000
2021-09-29	2021-09-27	4	Lucchese Joseph	TMBR	Stock Option (right to buy)	A - Award	D	0.92		361,163		361,163
2021-09-16	2021-09-14	4	Rome Zachary	TMBR	Stock Option (right to buy)	A - Award	D	0.89		561,000		561,000
2021-09-16	2021-09-14	4	Koconis John	TMBR	Stock Option (right to buy)	A - Award	D	0.89		890,000		890,000
2021-09-02	2021-09-02	4	TardiMed Sciences LLC	TMBR	Common Stock, par value $0.001 per share	S - Sale	D		0.9376	-225,000	-211		3,508,567
2021-09-01	2021-09-01	4	TardiMed Sciences LLC	TMBR	Common Stock, par value $0.001 per share	S - Sale	D		0.9227	-150,500	-139		3,733,567
2021-09-01	2021-08-31	4	TardiMed Sciences LLC	TMBR	Common Stock, par value $0.001 per share	S - Sale	D		0.9116	-150,000	-137		3,884,067
2021-09-01	2021-08-30	4	TardiMed Sciences LLC	TMBR	Common Stock, par value $0.001 per share	S - Sale	D		0.9266	-100,000	-93		4,034,067
2021-08-26	2021-08-26	4	TardiMed Sciences LLC	TMBR	Common Stock, par value $0.001 per share	S - Sale	D		0.9184	-100,000	-92		4,134,067
2021-08-26	2021-08-25	4	TardiMed Sciences LLC	TMBR	Common Stock, par value $0.001 per share	S - Sale	D		0.9126	-100,000	-91		4,234,067
2021-08-26	2021-08-24	4	TardiMed Sciences LLC	TMBR	Common Stock, par value $0.001 per share	S - Sale	D		0.9253	-100,000	-93		4,334,067
2021-08-20	2021-08-20	4	TardiMed Sciences LLC	TMBR	Common Stock, par value $0.001 per share	S - Sale	D		0.9079	-50,000	-45		4,434,067
2021-08-20	2021-08-19	4	TardiMed Sciences LLC	TMBR	Common Stock, par value $0.001 per share	S - Sale	D		0.9540	-50,000	-48		4,484,067
2021-08-20	2021-08-18	4	TardiMed Sciences LLC	TMBR	Common Stock, par value $0.001 per share	S - Sale	D		1.0010	-75,000	-75		4,534,067
2021-07-06	2021-07-01	4	Mendelsohn Alan	TMBR	Stock Option (right to buy)	A - Award	D	1.18		347,991		347,991
2021-07-06	2021-07-01	4	Pirozzi Gianluca	TMBR	Stock Option (right to buy)	A - Award	D	1.18		47,623		47,623
2021-07-06	2021-07-01	4	Sitar Edward J	TMBR	Stock Option (right to buy)	A - Award	D	1.18		47,623		47,623
2021-07-06	2021-07-01	4	Cohen David E	TMBR	Stock Option (right to buy)	A - Award	D	1.18		71,893		71,893
2021-07-06	2021-07-01	4	Gaal Lubor	TMBR	Stock Option (right to buy)	A - Award	D	1.18		71,893		71,893
2021-06-15	2021-06-15	4	TardiMed Sciences LLC	TMBR	Common Stock, par value $0.001 per share	S - Sale	D		1.2627	-28,450	-36		4,609,067
2021-06-15	2021-06-14	4	TardiMed Sciences LLC	TMBR	Common Stock, par value $0.001 per share	S - Sale	D		1.2669	-146,465	-186		4,637,517
2021-06-10	2021-06-10	4	TardiMed Sciences LLC	TMBR	Common Stock, par value $0.001 per share	S - Sale	D		1.2629	-185,229	-234		4,783,982
2021-06-10	2021-06-09	4	TardiMed Sciences LLC	TMBR	Common Stock, par value $0.001 per share	S - Sale	D		1.2739	-96,481	-123		4,969,211
2021-06-10	2021-06-08	4	TardiMed Sciences LLC	TMBR	Common Stock, par value $0.001 per share	S - Sale	D		1.2875	-305,540	-393		5,065,692
2021-06-02	2021-06-02	4	TardiMed Sciences LLC	TMBR	Common Stock, par value $0.001 per share	S - Sale	D		1.2600	-9,879	-12		5,371,232
2021-06-02	2021-06-01	4	TardiMed Sciences LLC	TMBR	Common Stock, par value $0.001 per share	S - Sale	D		1.2632	-8,670	-11		5,381,111
2021-06-02	2021-05-28	4	TardiMed Sciences LLC	TMBR	Common Stock, par value $0.001 per share	S - Sale	D		1.2699	-47,736	-61		5,389,781
2021-05-13	2021-03-03	4	Mendelsohn Alan By spouse	TMBR	Common Stock, par value $0.001 per share	P - Purchase	I		2.1700	1,988	4		1,988
2020-09-16	2020-09-16	4	TardiMed Sciences LLC	TMBR	Common Stock, par value $0.001 per share	S - Sale	D		1.0298	-100,694	-104		5,437,517
2020-09-16	2020-09-15	4	TardiMed Sciences LLC	TMBR	Common Stock, par value $0.001 per share	S - Sale	D		1.0286	-87,060	-90		5,538,211
2020-09-16	2020-09-14	4	TardiMed Sciences LLC	TMBR	Common Stock, par value $0.001 per share	S - Sale	D		1.0300	-455	-0		5,625,271
2020-09-14	2020-09-11	4	TardiMed Sciences LLC	TMBR	Common Stock, par value $0.001 per share	S - Sale	D		1.0303	-7,483	-8		5,625,726
2020-09-14	2020-09-10	4	TardiMed Sciences LLC	TMBR	Common Stock, par value $0.001 per share	S - Sale	D		1.0436	-32,943	-34		5,633,209
2020-06-09	2020-06-08	4	BROENNIMAN LINDA A	TMBR	Stock Option (right to buy)	A - Award	D	2.87		24,270		24,270
2020-06-09	2020-06-08	4	Stocum Michael	TMBR	Stock Option (right to buy)	A - Award	D	2.87		24,270		24,270
2020-06-09	2020-06-08	4	Lucchese Joseph	TMBR	Stock Option (right to buy)	A - Award	D	2.87		97,083		97,083
2020-06-09	2020-06-08	4	Pirozzi Gianluca	TMBR	Stock Option (right to buy)	A - Award	D	2.87		24,270		24,270
2020-06-09	2020-06-08	4	Sitar Edward J	TMBR	Stock Option (right to buy)	A - Award	D	2.87		24,270		24,270
2020-06-09	2020-06-08	4	Bragg Kimberly	TMBR	Stock Option (right to buy)	A - Award	D	2.87		38,833		38,833
2020-05-20	2020-05-18	4	Koconis John	TMBR	Value Appreciation Rights	A - Award	D	0.01		209,646		209,646
2020-05-20	2020-05-18	4	Rome Zachary	TMBR	Value Appreciation Rights	A - Award	D	0.01		132,209		132,209
2020-05-20	2020-05-18	4	Tavakkol Amir	TMBR	Value Appreciation Rights	A - Award	D	0.01		8,184		8,184
2020-05-20	2020-05-18	4	TardiMed Sciences LLC	TMBR	Series A Preferred Stock	J - Other	D			1,821		1,821
2020-05-20	2020-05-18	4	TardiMed Sciences LLC	TMBR	Common Stock, par value $0.001 per share	J - Other	D			5,666,152			5,666,152
2020-02-12	2020-02-10	4	Timber Pharmaceuticals LLC	BPMX	Common Stock, par value $0.01 per share	S - Sale	D		0.0100	-55,008	-1		2,200,328
2020-02-12	2020-02-10	4	Timber Pharmaceuticals LLC	BPMX	Common Stock, par value $0.01 per share	X - Other	D		0.0100	2,255,336	23		2,255,336
2020-02-12	2020-02-10	4	TardiMed Sciences LLC	BPMX	Warrant (right to buy)	X - Other	I	0.01		-2,225,336		0
2020-02-12	2020-02-10	4	TardiMed Sciences LLC	BPMX	Common Stock, par value $0.01 per share	S - Sale	I		0.0100	-55,008	-1		2,200,328
2020-02-12	2020-02-10	4	TardiMed Sciences LLC	BPMX	Common Stock, par value $0.01 per share	X - Other	I		0.0100	2,255,336	23		2,255,336
2019-07-18	2019-07-16	4	Bosacki Steven	BPMX	Option to purchase common stock	A - Award	D	0.44	0.4400	91,000	40	91,000
2019-07-18		3	Bosacki Steven	BPMX	No securities beneficially owned		D						0
2019-06-27	2019-06-25	4	Vivo Capital VIII, LLC	BPMX	Common Stock	S - Sale	I		1.0200	-327,870	-334		317,270
2019-06-14	2019-06-12	4	Goto Joyce	BPMX	Option to purchase common stock	A - Award	D	0.84	0.8400	70,000	59	70,000
2019-06-14	2019-06-12	4	Tierney David S	BPMX	Option to purchase common stock	A - Award	D	0.84	0.8400	360,000	302	360,000
2019-06-14	2019-06-12	4	Chan Kin Foong	BPMX	Option to purchase common stock	A - Award	D	0.84	0.8400	77,100	65	77,100
2019-06-14	2019-06-12	4	Morlock Stephen	BPMX	Option to purchase common stock	A - Award	D	0.84	0.8400	32,700	27	32,700
2019-06-14	2019-06-12	4	Plott Ronald Todd	BPMX	Option to purchase common stock	A - Award	D	0.84	0.8400	32,700	27	32,700
2019-06-14	2019-06-12	4	Hubbard Michael	BPMX	Option to purchase common stock	A - Award	D	0.84	0.8400	32,700	27	32,700
2019-02-21	2019-02-01	4	Plott Ronald Todd	BPMX	Option to purchase common stock	A - Award	D	0.20	0.2000	51,000	10	418,000
2019-02-21	2019-02-01	4	Plott Ronald Todd	BPMX	Option to purchase common stock	A - Award	D	0.20	0.2000	34,000	7	367,000
2019-02-21	2019-02-01	4	Plott Ronald Todd	BPMX	Option to purchase common stock	A - Award	D	0.11	0.1100	200,000	22	333,000
2019-02-21	2019-02-01	4	Plott Ronald Todd	BPMX	Option to purchase common stock	A - Award	D	0.11	0.1100	133,000	15	133,000
2019-02-21		3	Plott Ronald Todd	BPMX	No securities beneficially owned		D						0
2019-01-25	2019-01-23	4	Krammer Anja B	BPMX	Common stock	S - Sale	D		0.1100	-115,874	-13		1,884,126
2018-10-31	2018-10-30	4	Goto Joyce	BPMX	Option to purchase common stock	A - Award	D	0.20	0.2000	77,000	15	77,000
2018-10-31	2018-10-30	4	Goto Joyce	BPMX	Option to purchase common stock	A - Award	D	0.17	0.1700	470,000	80	470,000
2018-10-22	2018-10-22	4	Morlock Stephen By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03	BPMX	Common stock	S - Sale	I		0.1800	-251,071	-45		0
2018-10-22	2018-10-22	4	Morlock Stephen	BPMX	Common stock	S - Sale	D		0.1800	-220,766	-40		0
2018-10-22	2018-10-19	4	Morlock Stephen	BPMX	Common stock	S - Sale	D		0.1800	-214,091	-39		220,766
2018-10-22	2018-10-18	4	Morlock Stephen	BPMX	Common stock	S - Sale	D		0.1900	-439,099	-83		434,857
2018-10-12	2018-10-12	4	Krammer Anja B	BPMX	Common stock	S - Sale	D		0.1900	-297,500	-57		2,000,000
2018-10-12	2018-10-11	4	Krammer Anja B	BPMX	Common stock	S - Sale	D		0.1900	-100,000	-19		2,297,500
2018-10-12	2018-10-10	4	Krammer Anja B	BPMX	Common stock	S - Sale	D		0.1900	-102,500	-19		2,397,500
2018-09-20	2018-09-19	4	Tierney David S	BPMX	Common Stock	P - Purchase	D		0.2025	100,000	20		7,500,000
2018-09-13		3	Tierney David S	BPMX	No securities beneficially owned		D						0
2018-09-13	2018-09-11	4	Tierney David S	BPMX	Option to purchase common stock	A - Award	D	0.22	0.2200	7,400,000	1,628	7,400,000
2018-09-11	2018-09-10	4	Krammer Anja B	BPMX	Option to purchase common stock	A - Award	D	0.20		1,042,000		1,042,000
2018-03-09	2018-03-07	4	Vivo Capital VIII, LLC	BPMX	Common Stock	S - Sale	I		0.3600	-2,000,000	-720		16,128,515
2018-01-31	2018-01-30	4	Vivo Capital VIII, LLC	BPMX	Series A Convertible Preferred Stock	C - Conversion	I			-1,515		0
2018-01-31	2018-01-30	4	Vivo Capital VIII, LLC	BPMX	Common Stock	C - Conversion	I			4,328,571			18,128,515
2018-01-09	2018-01-08	4	Krammer Anja B	bpmx	Option to purchase common stock	A - Award	D	0.11		1,960,000		1,960,000
2017-12-22	2017-12-20	4	Chan Kin Foong	BPMX	Employee Stock Option (right to buy)	A - Award	D	0.20		414,000		414,000
2017-12-22	2017-12-20	4	Chan Kin Foong	BPMX	Employee Stock Option (right to buy)	A - Award	D	0.10		900,000		900,000
2017-12-22	2017-12-20	4	Hubbard Michael	BPMX	Director Stock Option (right to buy)	A - Award	D	0.20		205,000		205,000
2017-12-22	2017-12-20	4	Hubbard Michael	BPMX	Director Stock Option (right to buy)	A - Award	D	0.10		450,000		450,000
2017-12-22	2017-12-20	4	Kitchener Gregory David	BPMS	Employee Stock Option (right to buy)	A - Award	D	0.20		414,000		414,000
2017-12-22	2017-12-20	4	Kitchener Gregory David	BPMS	Employee Stock Option (right to buy)	A - Award	D	0.10		900,000		900,000
2017-12-22	2017-12-20	4	Krammer Anja B	BPMX	Employee Stock Option (right to buy)	A - Award	D	0.10		940,000		940,000
2017-12-22	2017-12-20	4	Morlock Stephen	BPMX	Director Stock Option (right to buy)	A - Award	D	0.20		205,000		205,000
2017-12-22	2017-12-20	4	Morlock Stephen	BPMX	Director Stock Option (right to buy)	A - Award	D	0.10		450,000		450,000
2017-11-27	2017-11-24	4	Morlock Stephen	bpmx	Warrant to purchase common stock	P - Purchase	D	0.25		330,000		330,000
2017-11-27	2017-11-24	4	Morlock Stephen	bpmx	Warrant to purchase common stock	P - Purchase	D	0.20		330,000		330,000
2017-11-27	2017-11-24	4	Morlock Stephen	bpmx	Common stock	P - Purchase	D		0.1500	330,000	50		873,956
2017-11-13	2017-11-09	4	Vivo Capital VIII, LLC	BPMX	Common Stock	S - Sale	I		0.2000	-296,394	-59		13,799,944
2017-08-03	2017-08-01	4	FRANKLIN RESOURCES INC	BPMX	Common Stock	P - Purchase	I		0.3372	250,000	84		9,749,615
2017-05-01	2017-04-28	4	Vivo Capital Fund VIII, L.P.	BPMX	Common Stock Warrant (right to buy)	P - Purchase	I	0.90		641,026		641,026
2017-05-01	2017-04-28	4	Vivo Capital Fund VIII, L.P.	BPMX	Common Stock	P - Purchase	I		0.7800	1,282,052	1,000		14,096,338
2017-04-19	2017-04-18	4	Chan Kin Foong	bpmx	Option to purchase common stock	A - Award	D	0.74	0.7400	435,000	322	435,000
2017-04-19	2017-04-18	4	Kitchener Gregory David	bpmx	Option to purchase common stock	A - Award	D	0.74	0.7400	290,000	215	290,000
2017-04-19	2017-04-18	4	Krammer Anja B	bpmx	Option of purchase common stock	A - Award	D	0.74	0.7400	1,060,000	784	1,060,000
2017-04-19	2017-04-18	4	VONTZ CHARLES GREGORY	bpmx	Option to purchase common stock	A - Award	D	0.74	0.7400	200,000	148	200,000
2017-04-19	2017-04-18	4	Morlock Stephen By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03	bpmx	Option to purchase common stock	A - Award	I	0.74	0.7400	200,000	148	200,000
2017-04-19	2017-04-18	4	Hubbard Michael	bpmx	Option to purchase common stock	A - Award	D	0.74	0.7400	200,000	148	200,000
2017-01-20		3	VONTZ CHARLES GREGORY	bpmx	No securities beneficially owned		D						0
2017-01-20	2017-01-18	4	VONTZ CHARLES GREGORY	bpmx	Option to purchase common stock	A - Award	D	0.45	0.4500	60,000	27	60,000
2017-01-20	2017-01-18	4	VONTZ CHARLES GREGORY	bpmx	Option to purchase common stock	A - Award	D	0.45	0.4500	65,000	29	65,000
2016-12-12	2016-12-08	4	Krammer Anja B	bpmx	Option to purchase common stock	A - Award	D	0.42	0.4200	400,000	168	400,000
2016-12-12	2016-12-08	4	Chan Kin Foong	bpmx	Option to purchase common stock	A - Award	D	0.42	0.4200	150,000	63	150,000
2016-12-12	2016-12-08	4	Hubbard Michael	bpmx	Option to purchase common stock	A - Award	D	0.42	0.4200	150,000	63	150,000
2016-12-12	2016-12-08	4	Morlock Stephen By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03	bpmx	Option to purchase common stock	A - Award	I	0.42	0.4200	150,000	63	150,000
2016-12-12	2016-12-08	4	Kitchener Gregory David	bpmx	Option to purchase common stock	A - Award	D	0.42	0.4200	175,000	74	175,000
2016-12-02		3	Vivo Capital VIII, LLC	BPMX	Common Stock		I						25,628,572
2016-12-02		3	Vivo Capital VIII, LLC	BPMX	Common Stock		I						25,628,572
2016-11-30	2016-11-22	4	FRANKLIN RESOURCES INC	BPMX	Class A Warrants	P - Purchase	I	0.35		4,375,000		4,375,000
2016-11-30	2016-11-22	4	FRANKLIN RESOURCES INC	BPMX	Common Stock	P - Purchase	I			4,375,000			9,499,615
2016-11-29	2016-11-28	4/A	Morlock Stephen	bpmx	Warrants to purchase common stock	P - Purchase	D	0.35		321,428		321,428
2016-11-29	2016-11-28	4/A	Morlock Stephen	bpmx	Common stock	P - Purchase	D		0.3500	428,571	150		543,956
2016-11-29	2016-11-28	4	Morlock Stephen	bpmx	Warrants to purchase common stock	A - Award	D	0.35	0.3500	321,428	112	496,428
2016-11-29	2016-11-28	4	Morlock Stephen By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03	bpmx	Common stock	A - Award	I			0			251,071
2016-11-29	2016-11-28	4	Morlock Stephen	bpmx	Common stock	A - Award	D		0.3500	428,571	150		543,956
2016-08-16	2016-08-12	4	Morlock Stephen By family trust	bpmx	Common stock	A - Award	I			0			251,071
2016-08-16	2016-08-12	4	Morlock Stephen	bpmx	Common stock	A - Award	D		0.6500	115,385	75		115,385
2016-08-16	2016-08-15	4	FRANKLIN RESOURCES INC	BPMX	Common Stock	P - Purchase	I		0.6500	484,615	315		5,124,615
2016-07-25	2016-07-21	4	Barbarosh Craig A.	bpmx	Option to purchase common stock	A - Award	D	0.62	0.6200	65,000	40	175,000
2016-07-25	2016-07-21	4	Krammer Anja B	bpmx	Option to purchase common stock	A - Award	D	0.62	0.6200	360,000	223	465,000
2016-07-25	2016-07-21	4	Chan Kin Foong	bpmx	Option to purchase common stock	A - Award	D	0.62	0.6200	170,000	105	225,000
2016-07-25	2016-07-21	4	Hubbard Michael	bpmx	Option to purchase common stock	A - Award	D	0.62	0.6200	65,000	40	195,000
2016-07-25	2016-07-21	4	Morlock Stephen By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03	bpmx	Option to purchase common stock	A - Award	I	0.62	0.6200	65,000	40	175,000
2016-07-25	2016-07-21	4	Kitchener Gregory David	bpmx	Option to purchase common stock	A - Award	D	0.62	0.6200	110,000	68	400,000
2016-07-06	2016-07-01	4	Krammer Anja B	BPMX	Option to purchase common stock	A - Award	D	0.65	0.6500	105,000	68	105,000
2016-07-06	2016-07-01	4	Chan Kin Foong	BPMX	Option to purchase common stock	A - Award	D	0.65	0.6500	55,000	36	55,000
2016-07-06	2016-07-01	4	Kitchener Gregory David	bpmx	Option to purchase common stock	A - Award	D	0.65	0.6500	55,000	36	290,000
2016-06-14	2016-06-13	4	Barbarosh Craig A.	BPMX	Option to purchase common stock	A - Award	D	0.76	0.7600	60,000	46	110,000
2016-06-14	2016-06-13	4	Hubbard Michael	BPMX	Option to purchase common stock	A - Award	D	0.76	0.7600	80,000	61	130,000
2016-06-14	2016-06-13	4	Morlock Stephen By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03	BPMX	Option to purchase common stock	A - Award	I	0.76	0.7600	60,000	46	110,000
2016-03-31	2016-03-29	4	FRANKLIN RESOURCES INC	BPMX	Warrants	P - Purchase	I	1.20		270,000		270,000
2016-03-31	2016-03-29	4	FRANKLIN RESOURCES INC	BPMX	Common Stock	P - Purchase	I		1.2000	540,000	648		4,640,000
2016-01-27		3	Barbarosh Craig A.	bpmx	No securities are beneficially owned		D						0
2016-01-27	2016-01-26	4	Barbarosh Craig A.	bpmx	Option to purchase common stock	A - Award	D	1.55	1.5500	50,000	78	50,000
2016-01-15	2016-01-14	4	Morlock Stephen By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03	bpmx	Common stock	P - Purchase	I		1.5300	5,500	8		251,071
2016-01-15	2016-01-13	4	Morlock Stephen By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03	bpmx	Common stock	P - Purchase	I		1.5200	6,500	10		245,571
2016-01-12	2016-01-12	4	Morlock Stephen By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03	bpmx	Common stock	P - Purchase	I		1.6300	3,000	5		239,071
2016-01-12	2016-01-11	4	Morlock Stephen By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03	bpmx	Common stock	P - Purchase	I		1.4300	3,000	4		236,071
2016-01-11	2016-01-07	4	Morlock Stephen By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03	BPMX	Common stock	P - Purchase	I		1.4700	5,000	7		233,071
2015-12-21		3	FRANKLIN RESOURCES INC	BPMX	Common Stock		I						8,200,000
2015-12-21		3	FRANKLIN RESOURCES INC	BPMX	Common Stock		I						8,200,000
2015-10-15	2015-10-15	4	Morlock Stephen By Stephen W. Morlock and Karen R. Morlock TTE UPT dated 04/21/03	bpmx	Common stock	P - Purchase	I		1.2300	3,000	4		228,071
2015-10-15	2015-10-14	4	Morlock Stephen By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03	bpmx	Common stock	P - Purchase	I		1.2500	2,000	2		225,071
2015-10-13	2015-10-09	4	Morlock Stephen	bpmx	Common stock	P - Purchase	D		1.1900	2,000	2		223,071
2015-10-13	2015-10-09	4	Morlock Stephen	bpmx	Common stock	P - Purchase	D		1.2600	1,000	1		221,071
2015-08-12		3	Kitchener Gregory David	BPMX	No securities are beneficially owned		D						0
2015-08-12	2015-08-10	4	Kitchener Gregory David	BPMX	Option to purchase common stock	A - Award	D	1.67	1.6700	235,000	392	235,000
2015-07-02		3/A	Morlock Stephen By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03	BPMX	Common Stock		I						204,868
2015-07-02	2015-06-30	4	Morlock Stephen By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03	BPMX	Common Stock	A - Award	I			1,364			220,071
2015-06-29	2015-06-25	4	Morlock Stephen By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03	BPMX	Series A Convertible Preferred Stock	C - Conversion	I			-13,514		0
2015-06-29	2015-06-25	4	Morlock Stephen By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03	BPMX	Common Stock	C - Conversion	I			13,839			218,707
2015-05-01	2015-04-30	4	Hubbard Michael	bpmx	Option to purchase common stock	A - Award	D	3.00	3.0000	50,000	150	50,000
2015-05-01	2015-04-30	4	Morlock Stephen	bpmx	Option to purchase common stock	A - Award	D	3.00	3.0000	50,000	150	50,000
2015-04-01		3	Morlock Stephen By Stephen W. Morlock and Karen R. Morlock TIEE UPT dated 04/21/03	BPMX	Common Stock		I						355,136
2015-04-01		3	Morlock Stephen By Stephen W. Morlock and Karen R. Morlock TIEE UPT dated 04/21/03	BPMX	Common Stock		I						355,136
2015-02-13		3	Hubbard Michael	BPMX	No securities are beneficially owned		D						0
2015-02-09		3	Wang Ping	BPMX	Series A Preferred Stock-No Securities Beneficially Owned		D						0
2014-02-11		3	Chan Kin Foong	TPND	Common Stock		D						2,400,000
2014-02-11		3	Chan Kin Foong	TPND	Common Stock		D						2,400,000
2014-02-04		3	Krammer Anja B	TPND	Common Stock		D						2,500,000
2014-01-30		3	Pekarsky James	TPND	Common Stock		D						2,500,000
2013-12-13		3	Thompson Kade	TPND	Common Stock		D						7,000,000

Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo

Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo

Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)

Conversão de derivativo

Venda ou transferência de ativos de volta para a empresa

Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa

Doação de ativos pelo ou para o insider

Swaps de capital e transações de hedge similares

Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)

Uma transação voluntariamente reportada no Formulário 4

Outro (acompanhado de uma nota explicativa descrevendo a transação)

TMBR / Timber Pharmaceuticals Inc - Insider Trading and Ownership Report - SEC Form 3, 4, 5